For Immediate Release:
9 May 2018
Nirali Gada; [email protected]
Sachin Bangera; [email protected]
PETA India Appeal Prompts Government Institution to Take Compassionate Step
Delhi – Following suggestions from People for the Ethical Treatment of Animals (PETA) India, the Indian Pharmacopoeia Commission has made updates to Indian Pharmacopoeia, the official compilation of approved tests for drugs manufactured and marketed in India. The new edition allows companies to use a modern, animal-free test for drug contaminants that cause fever instead of subjecting rabbits to painful injections. The commission has also eliminated the requirement that companies force guinea pigs and mice to suffer and die in vaccine abnormal-toxicity tests that are no longer required in the United States or Europe.
“These progressive measures will spare rabbits and other animals immense suffering in cruel experiments,” says PETA India Science Policy Adviser Dr Dipti Kapoor. “The future of science is animal-free, and PETA India is calling for additional regulatory overhauls to replace all animal tests with modern, humane methods.”
PETA India – whose motto reads, in part, that “animals are not ours to experiment on” – notes that the vast physiological differences between humans and other species means the results of animal experiments are often misleading. The group will continue to work with government and industry stakeholders to promote the use of human-relevant, animal-free tests.
For more information, please visit PETAIndia.com.